PARP9 and neoplasm: Thus, our study provided first evidence that ARTD9 together with STAT1β may negatively regulate a tumor suppressor network, while ARTD9 may concomitantly positively regulate a STAT1- dependent and independent proto-oncogene network in HR-subtype DLBCL [470].